212 related articles for article (PubMed ID: 36356302)
21. BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.
Ullrich E; Abendroth B; Rothamer J; Huber C; Büttner-Herold M; Buchele V; Vogler T; Longerich T; Zundler S; Völkl S; Beilhack A; Rose-John S; Wirtz S; Weber GF; Ghimire S; Kreutz M; Holler E; Mackensen A; Neurath MF; Hildner K
J Clin Invest; 2018 Mar; 128(3):916-930. PubMed ID: 29376889
[TBL] [Abstract][Full Text] [Related]
22. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
[TBL] [Abstract][Full Text] [Related]
23. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
Front Immunol; 2021; 12():785774. PubMed ID: 34987512
[TBL] [Abstract][Full Text] [Related]
24. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway.
Liu L; Liang L; Yang C; Zhou Y; Chen Y
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33769187
[TBL] [Abstract][Full Text] [Related]
26.
Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
[TBL] [Abstract][Full Text] [Related]
27. The scaffold-dependent function of RIPK1 in dendritic cells promotes injury-induced colitis.
Moriwaki K; Park C; Koyama K; Balaji S; Kita K; Yagi R; Komazawa-Sakon S; Semba M; Asuka T; Nakano H; Kamada Y; Miyoshi E; Chan FKM
Mucosal Immunol; 2022 Jan; 15(1):84-95. PubMed ID: 34462571
[TBL] [Abstract][Full Text] [Related]
28. Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.
Mammadli M; Huang W; Harris R; Sultana A; Cheng Y; Tong W; Pu J; Gentile T; Dsouza S; Yang Q; Bah A; August A; Karimi M
Front Immunol; 2020; 11():593863. PubMed ID: 33324410
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
30. TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells.
Woznicki JA; Saini N; Flood P; Rajaram S; Lee CM; Stamou P; Skowyra A; Bustamante-Garrido M; Regazzoni K; Crawford N; McDade SS; Longley DB; Aza-Blanc P; Shanahan F; Zulquernain SA; McCarthy J; Melgar S; McRae BL; Nally K
Cell Death Dis; 2021 Sep; 12(10):864. PubMed ID: 34556638
[TBL] [Abstract][Full Text] [Related]
31. Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
Peng R; Wang CK; Wang-Kan X; Idorn M; Kjaer M; Zhou FY; Fiil BK; Timmermann F; Orozco SL; McCarthy J; Leung CS; Lu X; Bagola K; Rehwinkel J; Oberst A; Maelfait J; Paludan SR; Gyrd-Hansen M
EMBO Rep; 2022 Dec; 23(12):e55839. PubMed ID: 36268590
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
Liang S; Nian Z; Shi K
Biochem Biophys Res Commun; 2020 Jun; 526(4):1028-1035. PubMed ID: 32321638
[TBL] [Abstract][Full Text] [Related]
33. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
[TBL] [Abstract][Full Text] [Related]
34. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
[TBL] [Abstract][Full Text] [Related]
35. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity.
Sykes M; Abraham VS; Harty MW; Pearson DA
J Immunol; 1993 Jan; 150(1):197-205. PubMed ID: 8093257
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
[TBL] [Abstract][Full Text] [Related]
37. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
Front Immunol; 2018; 9():3016. PubMed ID: 30619360
[TBL] [Abstract][Full Text] [Related]
38. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
Choi J; Cooper ML; Staser K; Ashami K; Vij KR; Wang B; Marsala L; Niswonger J; Ritchey J; Alahmari B; Achilefu S; Tsunoda I; Schroeder MA; DiPersio JF
Leukemia; 2018 Nov; 32(11):2483-2494. PubMed ID: 29691471
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
Front Immunol; 2019; 10():295. PubMed ID: 30891031
[TBL] [Abstract][Full Text] [Related]
40. Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3.
Kang TB; Jeong JS; Yang SH; Kovalenko A; Wallach D
Cell Death Differ; 2018 Jun; 25(6):1107-1117. PubMed ID: 29666472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
